Experts in the field, along with patient representatives from the Sarcoma Patient Advocacy Global Network (SPAGN), met at an international consensus meeting in 2022 to define best clinical practice of tenosynovial giant cell tumour (TGCT). Although usually not life-threatening, TGCT may cause chronic pain and adversely impact function and quality of life. A global effort is needed to make active systemic treatments available to TGCT patients worldwide and avoid discrimination.
This Article supports SDGs 3 and 10 by showing that, globally, Black women are at higher risk of adverse perinatal outcomes of neonatal death, stillbirth, preterm birth, and small-for-gestational-age babies than White women, even after adjusting for maternal characteristics. Moreover, these racial disparities in perinatal outcomes were consistently observed across all geographical regions.
This Series paper supports SDGs 3 and 10 by focusing on wider societal action to confront the health effects of racism, highlighting that broader, deeper, transformative action is needed compared with current measures to tackle the adverse effects of racism on health.
Cabotegravir (CAB) is an integrase strand transfer inhibitor (INSTI) formulated as a long-acting injectable drug approved for pre-exposure prophylaxis and use with a long acting rilpivirine formulation for therapy in patients with virological suppression. However, there has been no comprehensive review of the genetic mechanisms of CAB resistance. Studies reporting the selection of drug resistance mutations (DRMs) by CAB and the results of in vitro CAB susceptibility testing were reviewed.
An ongoing challenge in HIV-1 vaccine research is finding a novel HIV-1 envelope glycoprotein (Env)-based immunogen that elicits broadly cross-neutralizing antibodies (bnAbs) without requiring complex sequential immunization regimens to drive the required antibody affinity maturation.
This Article supports SDG 8,9 and 10, by examining the direct relation between economic inequity and burden of disease due to air pollution in India considering time trends from 2011-2019.
This Study supports SDGs 3, 5 and 10 by exploring the national impact of limited English proficiency (LEP) in breast cancer screening. Previously unknown, the results showed that LEP women, particularly Spanish speakers, are associated with a lower probability of having a screening mammogram.
This Study supports SDGs 3, 5 and 10 by highlighting the significant variability in insurance coverage of Prophylactic Mastectomy (PM) between companies which can lead to further inequalities in access to this breast cancer risk reducing procedure. Physicians and patients alike should advocate for fair and equal access to PM for certain clinical indications.
This Article supports SDGs 3, 5 and 10, summarizing a discussion on workplace flexibility held by the AAWR at the RSNA 2021 Scientific Assembly and Annual Meeting, and highlighting the positive impact various aspects of flexible work arrangements have on women.
This Health Policy paper supports SDGs 3 and 10; the authors did an empirical analysis of the use of imagery by key global health stakeholders and showed that the narrative currently depicted in imagery is one of power imbalances, depicting women and children from low-income and middle-income countries with less dignity, respect, and power than those from high-income countries.
